Prevalence and disposition of drugs of abuse and opioid treatment drugs in oral fluid

Journal of Analytical Toxicology

Volumn 31, Issue 8, 2007, Pages 424-433

  Cone, Edward J ^a,d   Clarke, Joe ^b   Tsanaclis, Lolita ^c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Altrix Healthcare Ltd   (United Kingdom)

^c No 1 Pentwyn Business Centre   (United Kingdom)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 ACETYLCODEINE; AMPHETAMINE; BENZODIAZEPINE; BUPRENORPHINE; CANNABIDIOL; CANNABINOID; CANNABINOL; CHLORDIAZEPOXIDE; COCAINE; CODEINE; DIAZEPAM; DRUG METABOLITE; HOMOCOCAINE; LORAZEPAM; METHADONE; MORPHINE 6 ACETATE; NORDAZEPAM; OPIATE; OXAZEPAM; TEMAZEPAM; TETRAHYDROCANNABINOL; UNCLASSIFIED DRUG;

ARTICLE; BODY FLUID; CONTROLLED STUDY; DRUG ABUSE; DRUG DEPENDENCE; DRUG DISPOSITION; DRUG SCREENING; ENZYME IMMUNOASSAY; GAS CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MASS SPECTROMETER; OPIATE ADDICTION; PREVALENCE; WORKPLACE;

EID: 36448978515     PISSN: 01464760     EISSN: 01464760     Source Type: Journal    
DOI: 10.1093/jat/31.8.424     Document Type: Article

References (29)

1. E.J. Cone, A. Sampson-Cone, and M.A. Huestis. Interpreting alternative matrix test results. In Drug Abuse Handbook, S.B. Karch, Ed. CRC Press, Boca Raton, FL, 2007, pp 814-842.
2. E.J. Cone, J. Oyler, and W.D. Darwin. Cocaine disposition in saliva following intravenous, intranasal, and smoked administration. J. Anal. Toxicol. 21: 465-475 (1997).
3. A.J. Jenkins, J.M. Oyler, and E.J. Cone. Comparison of heroin and cocaine concentrations in saliva with concentrations in blood and plasma. J. Anal. Toxicol. 19: 359-374 (1995).
4. E.J. Cone. Saliva testing for drugs of abuse. Ann. N. Y. Acad. Sci. 694: 91-127 (1993).
5. 9- tetrahydrocannabinol in oral fluid to plasma after controlled administration of smoked cannabis. J. Anal. Toxicol. 28: 394-399 (2004).
6. B. Caddy. Saliva as a specimen for drug analysis. In Advances in Analytical Toxicology, R.C. Baselt, Ed. Biomedical Publications, Foster City, CA, 1984, pp 198-254.
7. W. Schramm, R.H. Smith, P.A. Craig, and D.A. Kidwell. Drugs of abuse in saliva: a review. J. Anal. Toxicol. 16: 1-9 (1992).
8. O.R. Idowu and B. Caddy. A review of the use of saliva in the forensic detection of drugs and other chemicals. J. Forensic Sci. Soc. 22: 123-135 (1982).
9. J.C. Mucklow, M.R. Bending, G.C. Kahn, and C.T. Dollery. Drug concentration in saliva. Clin. Pharmacol. Ther. 24: 563-570 (1978).
10. F.M. Wylie, H. Torrance, A. Seymour, S. Buttress, and J.S. Oliver. Drugs in oral fluid Part II. Investigation of drugs in drivers. Forensic Sci. Int. 150: 199-204 (2005).
11. A.G. Verstraete. Detection times of drugs of abuse in blood, urine, and oral fluid. Ther. Drug Monit. 26: 200-205 (2004).
12. R.E. Choo and M.A. Huestis. Oral fluid as a diagnostic tool. Clin. Chem. Lab Med. 42: 1273-1287 (2004).
13. L. Kadehjian. Legal issues in oral fluid testing. Forensic Sci. Int. 150: 151-160 (2005).
14. H.H. Maurer. Advances in analytical toxicology: the current role of liquid chromatography-mass spectrometry in drug quantification in blood and oral fluid. Anal. Bioanal. Chem. 381: 110-118 (2005).
15. L. Rivier. Techniques for analytical testing of unconventional samples. Baillieres Best. Pract. Res. Clin. Endocrinol. Metab 14: 147-165 (2000).
16. N. Samyn, A. Verstraete, C. van Haeren, and P. Kintz. Analysis of drugs of abuse in saliva. Forensic Sci. Rev. 11: 1-19 (1999).
17. E.J. Cone, L. Presley, M. Lehrer, W. Seiter, M. Smith, K. Kardos, D. Fritch, S. Salamone, and R.S. Niedbala. Oral fluid testing for drugs of abuse: Positive prevalence rates by Intercept™ immunoassay screening and GC-MS-MS confirmation and suggested cutoff concentrations. J. Anal. Toxicol. 26: 541-546 (2002).
18. E.D. Wish and G.S. Yacoubian, Jr. A comparison of the intercept oral specimen collection device to laboratory urinalysis among Baltimore City arrestees. Fed. Probation 66: 27-29 (2002).
19. Annual Report 2006: The State of the Drugs Problem in Europe, 2006, pp 1-96.
20. D.E. Moody. Drug interactions with benzodiazepines. In Handbook of Drug Interactions, A. Mozayani and L.P. Raymon, Eds. Humana Press, Totowa, NJ, 2004, pp 3-88.
21. J.J. Kuhlman, S. Lalani, J. Magluilo, B. Levine, W.D. Darwin, R.E. Johnson, and E.J. Cone. Human pharmacokinetics of intravenous, sublingual, and buccal buprenorphine. J. Anal. Toxicol. 20: 369-378 (1996).
22. 9-tetrahydrocannabinol-9-carboxylic acid in oral fluid specimens. J. Anal. Toxicol. 30: 409-412 (2006).
23. P. Jacob, III, R.T. Jones, N.L. Benowitz, A.T. Shulgin, E.R. Lewis, and B.A. Elias-Baker. Cocaine smokers excrete a pyrolysis product, anhydroecgonine methyl ester. J. Toxicol. Clin. Toxicol. 28: 121-125 (1990).
24. F.K. Rafla and R.L. Epstein. Identification of cocaine and its metabolites in human urine in the presence of ethyl alcohol. J. Anal. Toxicol. 3: 59-63 (1979).
25. G. Cooper, L. Wilson, C. Reid, D. Baldwin, C. Hand, and V. Spiehler. Comparison of GC-MS and EIA results for the analysis of methadone in oral fluid. J. Forensic Sci. 50: 928-932 (2005).
26. L. Presley, M. Lehrer, W. Seiter, D. Hahn, B. Rowland, M. Smith, K.W. Kardos, D. Fritch, S. Salamone, R.S. Niedbala, and E.J. Cone. High prevalence of 6-acetylmorphine in morphine-positive oral fluid specimens. Forensic Sci. Int. 133: 22-25 (2003).
27. C.L. O'Neal and A. Poklis. The detection of acetylcodeine and 6-acetylmorphine in opiate positive urines. Forensic Sci. Int. 95: 1-10 (1998).
28. E.J. Cone, W.D. Darwin, C.W. Gorodetzky, and T. Tan. Comparative metabolism of hydrocodone in man, rat, guinea pig, rabbit, and dog. Drug Metab. Dispos. 6: 488-493 (1978).
29. J. Fountain, J. Strang, M. Gossop, M. Farrell, and P. Griffiths. Diversion of prescribed drugs by drug users in treatment: analysis of the UK market and new data from London. Addiction 95: 393-406 (2000).